Free Trial

CorVel (CRVL) Competitors

CorVel logo
$117.12 -1.54 (-1.30%)
As of 04/16/2025 04:00 PM Eastern

CRVL vs. LH, DGX, DVA, CHE, AMED, MD, AMN, CCRN, RYAN, and ERIE

Should you be buying CorVel stock or one of its competitors? The main competitors of CorVel include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Ryan Specialty (RYAN), and Erie Indemnity (ERIE).

CorVel vs.

CorVel (NASDAQ:CRVL) and Laboratory Co. of America (NYSE:LH) are both business services companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings, valuation and community ranking.

CorVel has a net margin of 10.12% compared to Laboratory Co. of America's net margin of 5.73%. CorVel's return on equity of 32.22% beat Laboratory Co. of America's return on equity.

Company Net Margins Return on Equity Return on Assets
CorVel10.12% 32.22% 17.66%
Laboratory Co. of America 5.73%15.29%7.01%

In the previous week, Laboratory Co. of America had 3 more articles in the media than CorVel. MarketBeat recorded 25 mentions for Laboratory Co. of America and 22 mentions for CorVel. CorVel's average media sentiment score of 1.38 beat Laboratory Co. of America's score of 0.99 indicating that CorVel is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CorVel
18 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Laboratory Co. of America
16 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

CorVel has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Comparatively, Laboratory Co. of America has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.

Laboratory Co. of America received 431 more outperform votes than CorVel when rated by MarketBeat users. Likewise, 64.01% of users gave Laboratory Co. of America an outperform vote while only 63.73% of users gave CorVel an outperform vote.

CompanyUnderperformOutperform
CorVelOutperform Votes
195
63.73%
Underperform Votes
111
36.27%
Laboratory Co. of AmericaOutperform Votes
626
64.01%
Underperform Votes
352
35.99%

Laboratory Co. of America has a consensus target price of $268.77, indicating a potential upside of 21.84%. Given Laboratory Co. of America's stronger consensus rating and higher probable upside, analysts plainly believe Laboratory Co. of America is more favorable than CorVel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CorVel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Laboratory Co. of America
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.87

51.4% of CorVel shares are owned by institutional investors. Comparatively, 95.9% of Laboratory Co. of America shares are owned by institutional investors. 47.6% of CorVel shares are owned by insiders. Comparatively, 0.9% of Laboratory Co. of America shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Laboratory Co. of America has higher revenue and earnings than CorVel. Laboratory Co. of America is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CorVel$871.31M6.90$76.25M$1.7068.89
Laboratory Co. of America$13.01B1.42$746M$8.8225.01

Summary

Laboratory Co. of America beats CorVel on 12 of the 19 factors compared between the two stocks.

Remove Ads
Get CorVel News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRVL vs. The Competition

MetricCorVelInsurance agents, brokers, & service IndustryBusiness SectorNASDAQ Exchange
Market Cap$6.02B$18.84B$6.92B$7.35B
Dividend YieldN/A1.34%2.70%4.32%
P/E Ratio68.8925.0029.3517.68
Price / Sales6.905.57150.7392.89
Price / Cash57.1926.5531.6134.64
Price / Book19.9918.304.513.94
Net Income$76.25M$731.04M$195.82M$247.45M
7 Day Performance1.93%-2.19%1.01%3.17%
1 Month Performance10.27%-7.94%-9.08%-8.53%
1 Year Performance51.25%8.76%3.07%0.32%

CorVel Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRVL
CorVel
0.983 of 5 stars
$117.12
-1.3%
N/A+49.2%$6.02B$871.31M68.894,230Positive News
LH
Laboratory Co. of America
4.7281 of 5 stars
$223.47
-0.7%
$270.38
+21.0%
+9.2%$18.70B$13.01B25.3475,500Dividend Announcement
DGX
Quest Diagnostics
4.8508 of 5 stars
$164.53
+0.2%
$180.60
+9.8%
+29.2%$18.26B$9.87B21.3949,000Upcoming Earnings
Positive News
High Trading Volume
DVA
DaVita
3.7191 of 5 stars
$146.59
-1.9%
$166.33
+13.5%
+9.4%$11.73B$12.82B13.6570,000
CHE
Chemed
4.6862 of 5 stars
$575.33
-3.7%
$667.00
+15.9%
-4.3%$8.42B$2.43B29.0714,200Upcoming Earnings
Short Interest ↓
Positive News
AMED
Amedisys
3.2881 of 5 stars
$91.70
-0.2%
$101.00
+10.1%
+0.7%$3.01B$2.35B36.3920,000Upcoming Earnings
Analyst Forecast
News Coverage
Positive News
MD
Pediatrix Medical Group
2.226 of 5 stars
$13.11
-3.0%
$17.08
+30.4%
+47.6%$1.12B$2.01B-10.925,170Short Interest ↓
Positive News
Gap Down
AMN
AMN Healthcare Services
4.1591 of 5 stars
$19.73
-3.2%
$41.17
+108.6%
-67.8%$753.55M$2.98B-5.134,230Analyst Forecast
CCRN
Cross Country Healthcare
3.5633 of 5 stars
$14.09
-2.9%
$18.41
+30.6%
-17.1%$462.34M$1.34B-281.742,700Short Interest ↑
Positive News
RYAN
Ryan Specialty
2.7723 of 5 stars
$68.47
-2.9%
$75.27
+9.9%
+45.1%$17.93B$2.52B99.233,850High Trading Volume
ERIE
Erie Indemnity
1.9782 of 5 stars
$381.05
-3.9%
N/A+8.1%$17.60B$3.86B35.656,040Upcoming Earnings
Remove Ads

Related Companies and Tools


This page (NASDAQ:CRVL) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners